Mary Caffrey

Wells A. Messersmith, MD, co-director of the developmental therapeutics program at the University of Colorado Cancer Center, said work in this area is needed to fill the knowledge gaps in metastatic CRC, which has a 5-year survival rate of just 11%.

A study of patients with metastatic melanoma found that those who spent more time in hospice care lived almost four months longer than similar patients who had little or no hospice care, and that end-of-life costs dropped for those with more time in hospice.

For Amy Berman, BS, RN, today's cancer care delivery system is a lot like the sound of 1 hand clapping: It can be out of sync and unproductive, because it fails to touch the patients it treats.